NURS 684 Exam 3 Questions and Correct Answers the Latest Update

T/F? Bone density is recommended in all women 2 years post-menopause. FALSE The National Osteoporosis Foundation (NOF) and North American Menopause Society recommend that BMD (bone mineral density) be measured in - all women age 65 and older, regardless of clinical risk factors. - postmenopausal women with medical causes of bone loss regardless of age - postmenopausal women age 50 and over with additional risk factors - postmenopausal women with a low-trauma or fragility fracture ***remember 65+ unless reason! A 52-year-old woman presents with amenorrhea for one year and moderate hot flashes for 6 months. She is interested in bioidentical hormone relief for her hot flashes and wants to know if they are better for her than other hormones. Appropriate info to provide would be, what? 17 beta-estradiol is a bioidentical form of estrogen available in oral, transdermal, and vaginal formulations Bioidentical hormones are artificial hormones that are used to treat people with hormonal imbalances. Bioidentical hormone replacement therapy (BHRT) can help relieve symptoms of hormonal imbalances and menopause. TestTrackers: Unlock Your Exam Potential! | Quality Practice Materials | Boost Your Confidence Today! | Thank You for Choosing Us! © 2024 TestTrackers Customer Support: [] Resources & Updates: [Testtrackers - Stuvia US] Your Success is Our Mission! Which of the following statements concerning the estrogen agonist/antagonist raloxifine (Evista) is correct? It is approved for the prevention and treatment of osteoporosis. Raloxifene is in a class of medications called selective estrogen receptor modulators (SERMs). Raloxifene prevents and treats osteoporosis by mimicking the effects of estrogen (a female hormone produced by the body) to increase the density (thickness) of bone. Estrogen-mediated inhibition of bone resorption is a key player in normal bone remodeling. T/F? Data supports the use of topically applied progesterone creams for endometrial protection in menopausal women taking estrogen. FALSE The statement is false; current data does not support the use of topically applied progesterone creams as the sole method for endometrial protection in menopausal women taking estrogen, as the absorption through the skin is limited and does not reach sufficient blood levels to adequately protect the endometrium. It is good to know that Progesterone plays a crucial role in endometrial protection by counteracting the proliferative effects of estrogen, essentially preventing the uterine lining from growing too thick and reducing the risk of endometrial hyperplasia and cancer, especially when administered alongside estrogen therapy in postmenopausal women with an intact uterus; this means that adequate progesterone levels are necessary to maintain a healthy endometrium. What would NOT be an expected finding in a pelvic examination of a 70-year-old woman? TestTrackers: Unlock Your Exam Potential! | Quality Practice Materials | Boost Your Confidence Today! | Thank You for Choosing Us! © 2024 TestTrackers Customer Support: [] Resources & Updates: [Testtrackers - Stuvia US] Your Success is Our Mission! Ovaries easily palpable A menopausal woman experiencing discomfort with sexual intercourse related to vaginal dryness wants to know whether she should use a vaginal lubricant or a vaginal moisturizer. What would NOT be a true statement? a. Lubricants are intended to reduce friction r/t sex b. Lubricants can take several weeks of use before becoming effective c. Moisturizers provide long-term relief of vaginal dryness than lubricants d. Moisturizers are typically applied several times weekly B. is FALSE, lubricants are effective immedi